{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:01:31Z","timestamp":1793642491156,"version":"4.5.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Susan and Charles Berghoff Foundation"},{"name":"NIH","award":["1R21NS130500-01"],"award-info":[{"award-number":["1R21NS130500-01"]}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-23-1-0416"],"award-info":[{"award-number":["HT9425-23-1-0416"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While it is clear that inflammation contributes to Parkinson\u2019s disease (PD) and prevalence is higher in males, sex remains an underexplored determinant of immune responses in PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the 3KL transgenic mouse model, which expresses three E to K \u03b1-synuclein mutations, we investigated how sex and age shape peripheral and central immunity and behavior in synucleinopathy. Male and female 3KL mice were aged to 8- and 14-months. At these ages animals underwent motor and cognitive assessment, followed by assessment of the peripheral immune response using flow cytometry and analysis of microglial transcriptional profiles by bulk RNA sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Male 3KL mice exhibited earlier onset and greater severity of motor and cognitive impairments, which was linked to a pro-inflammatory peripheral immune profile marked by increased cytotoxic CD8\u207a T cells and IFN\u03b3-producing CD4 Th1 cells. In contrast, female mice displayed delayed symptom onset, preserved cognition, along with early elevations in regulatory IL-10\u207a CD4 and \u03b3\u03b4 T cells. RNA sequencing of microglia revealed broad sex differences at 8 months. Males demonstrated early upregulation of microglia neurodegenerative signatures, MHC class I\/II signaling, ceramide signaling, and pronounced lipid dysregulation, while females showed upregulation of microglial pathways related to protein, metabolic, and neuronal maintenance, including phagosome formation, docosahexaenoic acid signaling, and synaptogenesis pathways. Microglial transcriptional differences were nearly absent by 14 months, suggesting sex-specific trajectories converge during late-stage disease, which is concurrent with a decrease in estrogen in aged female mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, these findings reveal distinct immune signaling in male and female 3KL mice and identify coordinated changes in T cell and microglial responses that may contribute to sex differences in PD vulnerability and progression. This work underscores the importance of incorporating sex as a biological variable in neurodegeneration research and provides mechanistic insight into immune-mediated modulation of synucleinopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13293-025-00809-1","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:21:58Z","timestamp":1766546518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sex-dependent immune activation shapes disease progression in a model of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Leah C.","family":"Beauchamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily A.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby B.","family":"Lanser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"8","key":"809_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of parkinson\u2019s disease. J Neural Transm (Vienna). 2017;124(8):901\u20135.","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"809_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol. 2003;157(11):1015\u201322.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"809_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/mdc3.13584","volume":"10","author":"A Zirra","year":"2023","unstructured":"Zirra A, Rao SC, Bestwick J, Rajalingam R, Marras C, Blauwendraat C, et al. Gender differences in the prevalence of Parkinson\u2019s Disease. Mov Disord Clin Pract. 2023;10(1):86\u201393.","journal-title":"Mov Disord Clin Pract"},{"issue":"13","key":"809_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390.","journal-title":"Mov Disord"},{"issue":"8","key":"809_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, et al. Gender differences in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2007;78(8):819\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"809_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/jcm12041329","volume":"12","author":"D Santos-Garc\u00eda","year":"2023","unstructured":"Santos-Garc\u00eda D, Laguna A, Hern\u00e1ndez-Vara J, de Deus Fonticoba T, Cores Bartolom\u00e9 C, Feal Painceiras MJ, et al. Sex differences in motor and non-motor symptoms among Spanish patients with Parkinson\u2019s disease. J Clin Med. 2023;12(4):1329. https:\/\/doi.org\/10.3390\/jcm12041329","journal-title":"J Clin Med"},{"issue":"3","key":"809_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F. Parkinson\u2019s disease in women and men: what\u2019s the difference? J Parkinsons Dis. 2019;9(3):501\u201315.","journal-title":"J Parkinsons Dis"},{"key":"809_CR8","doi-asserted-by":"publisher","first-page":"1204104","DOI":"10.3389\/fneur.2023.1204104","volume":"14","author":"K Raheel","year":"2023","unstructured":"Raheel K, Deegan G, Di Giulio I, Cash D, Ilic K, Gnoni V, et al. Sex differences in alpha-synucleinopathies: a systematic review. Front Neurol. 2023;14:1204104.","journal-title":"Front Neurol"},{"issue":"7","key":"809_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1212\/WNL.52.7.1417","volume":"52","author":"R Saunders-Pullman","year":"1999","unstructured":"Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of Estrogen replacement on early parkinson\u2019s disease. Neurology. 1999;52(7):1417\u201321.","journal-title":"Neurology"},{"issue":"11","key":"809_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10654-018-0399-3","volume":"33","author":"T Vlaar","year":"2018","unstructured":"Vlaar T, Kab S, Schwaab Y, Fr\u00e9ry N, Elbaz A, Moisan F. Association of parkinson\u2019s disease with industry sectors: a French nationwide incidence study. Eur J Epidemiol. 2018;33(11):1101\u201311.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"809_CR11","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1038\/s41598-019-47026-6","volume":"9","author":"YH Lee","year":"2019","unstructured":"Lee YH, Cha J, Chung SJ, Yoo HS, Sohn YH, Ye BS, et al. Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-na\u00efve postmenopausal parkinson\u2019s disease. Sci Rep. 2019;9(1):10531.","journal-title":"Sci Rep"},{"issue":"8","key":"809_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071634","volume":"8","author":"SJ Gardai","year":"2013","unstructured":"Gardai SJ, Mao W, Sch\u00fcle B, Babcock M, Schoebel S, Lorenzana C, et al. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson\u2019s disease. PLoS One. 2013;8(8):e71634.","journal-title":"PLoS One"},{"key":"809_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fnins.2018.00626","volume":"12","author":"LM Butkovich","year":"2018","unstructured":"Butkovich LM, Houser MC, Tansey MG. \u03b1-Synuclein and noradrenergic modulation of immune cells in parkinson\u2019s disease pathogenesis. Front NeuroSci. 2018;12:626.","journal-title":"Front NeuroSci"},{"issue":"7660","key":"809_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"issue":"1","key":"809_CR15","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, et al. alpha-Synuclein-specific T cell reactivity is associated with preclinical and early parkinson\u2019s disease. Nat Commun. 2020;11(1):1875.","journal-title":"Nat Commun"},{"issue":"7","key":"809_CR16","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awab122","volume":"144","author":"Y Xia","year":"2021","unstructured":"Xia Y, Zhang G, Kou L, Yin S, Han C, Hu J, et al. Reactive microglia enhance the transmission of exosomal \u03b1-synuclein via toll-like receptor 2. Brain. 2021;144(7):2024\u201337.","journal-title":"Brain"},{"issue":"3","key":"809_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, et al. Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia. 2013;61(3):349\u201360.","journal-title":"Glia"},{"issue":"11","key":"809_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/glia.20691","volume":"56","author":"JY Park","year":"2008","unstructured":"Park JY, Paik SR, Jou I, Park SM. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for parkinson\u2019s disease. Glia. 2008;56(11):1215\u201323.","journal-title":"Glia"},{"issue":"10","key":"809_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013481","volume":"5","author":"C Roodveldt","year":"2010","unstructured":"Roodveldt C, Labrador-Garrido A, Gonzalez-Rey E, Fernandez-Montesinos R, Caro M, Lachaud CC, et al. Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson\u2019s disease-linked mutants. PLoS One. 2010;5(10):e13481.","journal-title":"PLoS One"},{"issue":"2","key":"809_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of \u03b1-synuclein causes parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164\u201373.","journal-title":"Ann Neurol"},{"issue":"1","key":"809_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","volume":"100","author":"S Nuber","year":"2018","unstructured":"Nuber S, Rajsombath M, Minakaki G, Winkler J, M\u00fcller CP, Ericsson M, et al. Abrogating native \u03b1-Synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease. Neuron. 2018;100(1):75-90.e5.","journal-title":"Neuron"},{"issue":"38","key":"809_CR22","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1523\/JNEUROSCI.0313-19.2019","volume":"39","author":"MM Rajsombath","year":"2019","unstructured":"Rajsombath MM, Nam AY, Ericsson M, Nuber S. Female sex and brain-selective estrogen benefit \u03b1-Synuclein tetramerization and the PD-like motor syndrome in 3K transgenic mice. J Neurosci. 2019;39(38):7628\u201340.","journal-title":"J Neurosci"},{"issue":"46","key":"809_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1454","volume":"9","author":"TE Moors","year":"2023","unstructured":"Moors TE, Li S, McCaffery TD, Ho GPH, Bechade PA, Pham LN, et al. Increased palmitoylation improves estrogen receptor alpha-dependent hippocampal synaptic deficits in a mouse model of synucleinopathy. Sci Adv. 2023;9(46):eadj1454.","journal-title":"Sci Adv"},{"issue":"11","key":"809_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nmeth.2639","volume":"10","author":"S Picelli","year":"2013","unstructured":"Picelli S, Bj\u00f6rklund \u00c5K, Faridani OR, Sagasser S, Winberg G, Sandberg R. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods. 2013;10(11):1096\u20138.","journal-title":"Nat Methods"},{"issue":"12","key":"809_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"4","key":"809_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14(4):417\u20139.","journal-title":"Nat Methods"},{"issue":"10","key":"809_CR27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19(10):622\u201335.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"809_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u2013e819.","journal-title":"Immunity"},{"key":"809_CR29","doi-asserted-by":"crossref","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169(7):1276-90.e17.","DOI":"10.1016\/j.cell.2017.05.018"},{"issue":"5","key":"809_CR30","doi-asserted-by":"publisher","first-page":"C1264","DOI":"10.1152\/ajpcell.00177.2004","volume":"287","author":"F Tuluc","year":"2004","unstructured":"Tuluc F, Garcia A, Bredetean O, Meshki J, Kunapuli SP. Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways. Am J Physiol-Cell Physiol. 2004;287(5):C1264-72.","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"1","key":"809_CR31","doi-asserted-by":"publisher","first-page":"e20190945","DOI":"10.1084\/jem.20190945","volume":"217","author":"JA Hamilton","year":"2020","unstructured":"Hamilton JA. GM-CSF in inflammation. J Exp Med. 2020;217(1):e20190945. https:\/\/doi.org\/10.1084\/jem.20190945","journal-title":"J Exp Med"},{"issue":"9","key":"809_CR32","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.it.2020.07.003","volume":"41","author":"B Spittau","year":"2020","unstructured":"Spittau B, Dokalis N, Prinz M. The role of TGF\u03b2 signaling in microglia maturation and activation. Trends Immunol. 2020;41(9):836\u201348.","journal-title":"Trends Immunol"},{"issue":"1","key":"809_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.devcel.2019.02.014","volume":"49","author":"A Villani","year":"2019","unstructured":"Villani A, Benjaminsen J, Moritz C, Henke K, Hartmann J, Norlin N, et al. Clearance by microglia depends on packaging of phagosomes into a unique cellular compartment. Dev Cell. 2019;49(1):77-88.e7.","journal-title":"Dev Cell"},{"key":"809_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fphys.2020.00393","volume":"11","author":"BA Loving","year":"2020","unstructured":"Loving BA, Bruce KD. Lipid and lipoprotein metabolism in microglia. Front Physiol. 2020;11:393","journal-title":"Front Physiol"},{"key":"809_CR35","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3389\/fnins.2018.00381","volume":"12","author":"PAQ Videira","year":"2018","unstructured":"Videira PAQ, Castro-Caldas M. Linking glycation and glycosylation with inflammation and mitochondrial dysfunction in parkinson\u2019s disease. Front NeuroSci. 2018;12:2018.","journal-title":"Front NeuroSci"},{"issue":"1","key":"809_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/pr.117.014092","volume":"70","author":"S Lay\u00e9","year":"2018","unstructured":"Lay\u00e9 S, Nadjar A, Joffre C, Bazinet RP. Anti-inflammatory effects of Omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology. Pharmacol Rev. 2018;70(1):12\u201338.","journal-title":"Pharmacol Rev"},{"issue":"5","key":"809_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B, et al. Molecular actions of PPAR \u03b1 in lipid metabolism and inflammation. Endocr Rev. 2018;39(5):760\u2013802.","journal-title":"Endocr Rev"},{"issue":"3","key":"809_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"L Semenza Gregg","year":"2012","unstructured":"Semenza Gregg L. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399\u2013408.","journal-title":"Cell"},{"issue":"4","key":"809_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","volume":"88","author":"X Nan","year":"1997","unstructured":"Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997;88(4):471\u201381.","journal-title":"Cell"},{"issue":"24","key":"809_CR40","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1038\/sj.onc.1207671","volume":"23","author":"I Taniuchi","year":"2004","unstructured":"Taniuchi I, Littman DR. Epigenetic gene silencing by runx proteins. Oncogene. 2004;23(24):4341\u20135.","journal-title":"Oncogene"},{"issue":"5","key":"809_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1353-8020(02)00014-7","volume":"8","author":"LM Shulman","year":"2002","unstructured":"Shulman LM. Is there a connection between estrogen and Parkinson\u2019s disease? Parkinsonism Relat Disord. 2002;8(5):289\u201395.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"809_CR42","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","volume":"38","author":"S Jiang","year":"2017","unstructured":"Jiang S, Gao H, Luo Q, Wang P, Yang X. The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis. Neurol Sci. 2017;38(8):1373\u201380.","journal-title":"Neurol Sci"},{"issue":"7","key":"809_CR43","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.neurobiolaging.2011.02.016","volume":"33","author":"EN Mangano","year":"2012","unstructured":"Mangano EN, Litteljohn D, So R, Nelson E, Peters S, Bethune C, et al. Interferon-\u03b3 plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging. 2012;33(7):1411\u201326.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"809_CR44","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, et al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci. 2007;27(12):3328\u201337.","journal-title":"J Neurosci"},{"issue":"4","key":"809_CR45","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","volume":"164","author":"D Litteljohn","year":"2009","unstructured":"Litteljohn D, Mangano E, Shukla N, Hayley S. Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide Paraquat. Neuroscience. 2009;164(4):1894\u2013906.","journal-title":"Neuroscience"},{"issue":"1","key":"809_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","volume":"414","author":"M Mogi","year":"2007","unstructured":"Mogi M, Kondo T, Mizuno Y, Nagatsu T. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett. 2007;414(1):94\u20137.","journal-title":"Neurosci Lett"},{"issue":"4","key":"809_CR47","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/cddis.2011.17","volume":"2","author":"C Barcia","year":"2011","unstructured":"Barcia C, Ros CM, Annese V, G\u00f3mez A, Ros-Bernal F, Aguado-Yera D, et al. IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of parkinson\u2019s disease. Cell Death Dis. 2011;2(4):e142.","journal-title":"Cell Death Dis"},{"issue":"2","key":"809_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-3083.2006.01887.x","volume":"65","author":"CM Lezama-Davila","year":"2007","unstructured":"Lezama-Davila CM, Oghumu S, Satoskar AR, Isaac-Marquez AP. Sex-associated susceptibility in humans with chiclero\u2019s ulcer: resistance in females is associated with increased serum-levels of GM-CSF. Scand J Immunol. 2007;65(2):210\u20131.","journal-title":"Scand J Immunol"},{"issue":"13","key":"809_CR49","doi-asserted-by":"publisher","first-page":"e122998","DOI":"10.1172\/jci.insight.122998","volume":"5","author":"A Zychlinsky Scharff","year":"2019","unstructured":"Zychlinsky Scharff A, Rousseau M, Lacerda Mariano L, Canton T, Consiglio CR, Albert ML et al. Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection. JCI Insight. 2019;5(13):e122998","journal-title":"JCI Insight"},{"issue":"Pt 11","key":"809_CR50","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/brain\/120.11.2083","volume":"120","author":"RN McLay","year":"1997","unstructured":"McLay RN, Kimura M, Banks WA, Kastin AJ. Granulocyte-macrophage colony-stimulating factor crosses the blood\u2013brain and blood\u2013spinal cord barriers. Brain. 1997;120(Pt 11):2083\u201391.","journal-title":"Brain"},{"key":"809_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/srep00697","volume":"2","author":"M Krieger","year":"2012","unstructured":"Krieger M, Both M, Kranig SA, Pitzer C, Klugmann M, Vogt G, et al. The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Sci Rep. 2012;2:697.","journal-title":"Sci Rep"},{"issue":"5","key":"809_CR52","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1460-9568.2009.06653.x","volume":"29","author":"NK Kim","year":"2009","unstructured":"Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, et al. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson\u2019s disease model. Eur J Neurosci. 2009;29(5):891\u2013900.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"809_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/brb3.11","volume":"1","author":"ME Choudhury","year":"2011","unstructured":"Choudhury ME, Sugimoto K, Kubo M, Nagai M, Nomoto M, Takahashi H, et al. A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats. Brain Behav. 2011;1(1):26\u201343.","journal-title":"Brain Behav"},{"issue":"1","key":"809_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2011.02.011","volume":"43","author":"EN Mangano","year":"2011","unstructured":"Mangano EN, Peters S, Litteljohn D, So R, Bethune C, Bobyn J, et al. Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson\u2019s disease. Neurobiol Dis. 2011;43(1):99\u2013112.","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"809_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","volume":"265","author":"LM Kosloski","year":"2013","unstructured":"Kosloski LM, Kosmacek EA, Olson KE, Mosley RL, Gendelman HE. GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice. J Neuroimmunol. 2013;265(1\u20132):1\u201310.","journal-title":"J Neuroimmunol"},{"key":"809_CR56","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qiu AW, Huang Y, Yang Y, Chen JN, Gu TT, et al. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson\u2019s disease. Brain Behav Immun. 2019;81:630\u201345.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"809_CR57","doi-asserted-by":"publisher","first-page":"e0171790","DOI":"10.1371\/journal.pone.0171790","volume":"12","author":"CJ Zeiss","year":"2017","unstructured":"Zeiss CJ, Allore HG, Beck AP. Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson\u2019s disease. PLoS One. 2017;12(2):e0171790.","journal-title":"PLoS One"},{"issue":"2","key":"809_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/brainsci14020156","volume":"14","author":"RH Silva","year":"2024","unstructured":"Silva RH, Lopes-Silva LB, Cunha DG, Becegato M, Ribeiro AM, Santos JR. Animal approaches to studying risk factors for Parkinson\u2019s disease: a narrative review. Brain Sci. 2024;14(2):156. https:\/\/doi.org\/10.3390\/brainsci14020156","journal-title":"Brain Sci"},{"issue":"9","key":"809_CR59","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.molmed.2019.05.001","volume":"25","author":"L Kodama","year":"2019","unstructured":"Kodama L, Gan L. Do microglial sex differences contribute to sex differences in neurodegenerative diseases? Trends Mol Med. 2019;25(9):741\u20139.","journal-title":"Trends Mol Med"},{"key":"809_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107168","volume":"203","author":"R Gu","year":"2024","unstructured":"Gu R, Pan J, Awan MUN, Sun X, Yan F, Bai L, et al. The major histocompatibility complex participates in Parkinson\u2019s disease. Pharmacol Res. 2024;203:107168.","journal-title":"Pharmacol Res"},{"issue":"6","key":"809_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 2003;106(6):518\u201326.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"809_CR62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","volume":"14","author":"M-E Tremblay","year":"2019","unstructured":"Tremblay M-E, Cookson MR, Civiero L. Glial phagocytic clearance in Parkinson\u2019s disease. Mol Neurodegener. 2019;14(1):16.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"809_CR63","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/jnc.14225","volume":"143","author":"H Scheiblich","year":"2017","unstructured":"Scheiblich H, Schl\u00fctter A, Golenbock DT, Latz E, Martinez-Martinez P, Heneka MT. Activation of the NLRP3 inflammasome in microglia: the role of ceramide. J Neurochem. 2017;143(5):534\u201350.","journal-title":"J Neurochem"},{"key":"809_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070945","author":"A Custodia","year":"2021","unstructured":"Custodia A, Aramburu-N\u00fa\u00f1ez M, Correa-Paz C, Posado-Fern\u00e1ndez A, G\u00f3mez-Larrauri A, Castillo J, et al. Ceramide metabolism and Parkinson\u2019s disease-therapeutic targets. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11070945.","journal-title":"Biomolecules"},{"issue":"1","key":"809_CR65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-020-00408-1","volume":"15","author":"K Belarbi","year":"2020","unstructured":"Belarbi K, Cuvelier E, Bonte M-A, Desplanque M, Gressier B, Devos D, et al. Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease. Mol Neurodegener. 2020;15(1):59.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"809_CR66","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/jnr.21644","volume":"86","author":"S Shaikh","year":"2008","unstructured":"Shaikh S, Nicholson LF. Advanced glycation end products induce in vitro cross-linking of \u03b1\u2010synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res. 2008;86(9):2071\u201382.","journal-title":"J Neurosci Res"},{"issue":"20","key":"809_CR67","first-page":"3640","volume":"15","author":"M Kumari","year":"2024","unstructured":"Kumari M, Bisht KS, Ahuja K, Motiani RK, Maiti TK. Glycation produces topologically different \u03b1-Synuclein oligomeric strains and modulates microglia response via the NLRP3-Inflammasome pathway. ACS Chem Neurosci. 2024;15(20):3640\u20133654","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"809_CR68","doi-asserted-by":"publisher","first-page":"411","DOI":"10.33594\/000000668","volume":"57","author":"K Wieczorek-Szukala","year":"2023","unstructured":"Wieczorek-Szukala K, Markiewicz M, Walczewska A, Zgorzynska E. Docosahexaenoic acid (DHA) reduces LPS-induced inflammatory response via ATF3 transcription factor and stimulates Src\/Syk signaling-dependent phagocytosis in microglia. Cell Physiol Biochem. 2023;57(6):411\u201325.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"809_CR69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15548627.2019.1596488","volume":"16","author":"R Luo","year":"2020","unstructured":"Luo R, Su L-Y, Li G, Yang J, Liu Q, Yang L-X, et al. Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy. 2020;16(1):52\u201369.","journal-title":"Autophagy"},{"key":"809_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106593","volume":"199","author":"MA Adom","year":"2024","unstructured":"Adom MA, Hahn WN, McCaffery TD, Moors TE, Zhang X, Svenningsson P, et al. Reducing the lipase LIPE in mutant \u03b1-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism. Neurobiol Dis. 2024;199:106593.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"809_CR71","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/dneu.22814","volume":"81","author":"M Andoh","year":"2021","unstructured":"Andoh M, Koyama R. Microglia regulate synaptic development and plasticity. Dev Neurobiol. 2021;81(5):568\u201390.","journal-title":"Dev Neurobiol"},{"issue":"18","key":"809_CR72","doi-asserted-by":"publisher","first-page":"e98960","DOI":"10.15252\/embj.201898960","volume":"37","author":"SF Soukup","year":"2018","unstructured":"Soukup SF, Vanhauwaert R, Verstreken P. Parkinson\u2019s disease: convergence on synaptic homeostasis. Embo J. 2018;37(18):e98960","journal-title":"Embo J"},{"issue":"1","key":"809_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02079-1","volume":"18","author":"Y-N Zhang","year":"2021","unstructured":"Zhang Y-N, Fan J-K, Gu L, Yang H-M, Zhan S-Q, Zhang H. Metabotropic glutamate receptor 5 inhibits \u03b1-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson\u2019s disease. J Neuroinflammation. 2021;18(1):23.","journal-title":"J Neuroinflammation"},{"key":"809_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149649","volume":"1859","author":"S Usman","year":"2025","unstructured":"Usman S, Mondal AC. Menopause triggers microglia-associated neuroinflammation in Parkinson\u2019s disease. Brain Res. 2025;1859:149649.","journal-title":"Brain Res"},{"issue":"1","key":"809_CR75","doi-asserted-by":"publisher","first-page":"22864","DOI":"10.1038\/srep22864","volume":"6","author":"S-Y Wu","year":"2016","unstructured":"Wu S-Y, Chen Y-W, Tsai S-F, Wu S-N, Shih Y-H, Jiang-Shieh Y-F, et al. Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K\u2009+\u2009channel. Sci Rep. 2016;6(1):22864.","journal-title":"Sci Rep"},{"issue":"38","key":"809_CR76","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1523\/JNEUROSCI.0313-19.2019","volume":"39","author":"MM Rajsombath","year":"2019","unstructured":"Rajsombath MM, Nam AY, Ericsson M, Nuber S. Female sex and Brain-Selective Estrogen benefit \u03b1-Synuclein tetramerization and the PD-like motor syndrome in 3K Transgenic mice. J Neurosci. 2019;39(38):7628.","journal-title":"J Neurosci"},{"key":"809_CR77","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/B978-0-12-819410-2.00023-0","volume":"184","author":"F Garretti","year":"2022","unstructured":"Garretti F, Monahan C, Sette A, Agalliu D, Sulzer D. T cells, \u03b1-synuclein and Parkinson disease. Handb Clin Neurol. 2022;184:439\u201355.","journal-title":"Handb Clin Neurol"},{"key":"809_CR78","doi-asserted-by":"crossref","unstructured":"Wang S, Chu C-H, Stewart T, Ginghina C, Wang Y, Nie H, et al. \u03b1-Synuclein,a chemoattractant, directs microglial migration via H\u2009<\u2009sub\u2009>\u20092\u2009O\u2009<\u2009sub\u2009>\u20092-dependent Lyn phosphorylation. Proceedings of the National Academy of Sciences. 2015;112(15):E1926-E35.","DOI":"10.1073\/pnas.1417883112"},{"issue":"5","key":"809_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70275","volume":"21","author":"KA Wyman-Chick","year":"2025","unstructured":"Wyman-Chick KA, Ferman TJ, Armstrong MJ, Chrenka EAB, Chiu SY, Patel B, et al. Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer\u2019s Coordinating Center data. Alzheimers Dement. 2025;21(5):e70275.","journal-title":"Alzheimers Dement"},{"key":"809_CR80","doi-asserted-by":"publisher","first-page":"1432342","DOI":"10.3389\/fimmu.2024.1432342","volume":"15","author":"A Freuchet","year":"2024","unstructured":"Freuchet A, Pin\u00e7on A, Sette A, Lindestam Arlehamn CS. Inflammation and heterogeneity in synucleinopathies. Front Immunol. 2024;15:1432342.","journal-title":"Front Immunol"},{"issue":"1","key":"809_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli A, Camacho M, Allinson K, Williams-Gray CH. Neuroinflammation and protein pathology in parkinson\u2019s disease dementia. Acta Neuropathol Commun. 2020;8(1):211.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-025-00809-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-025-00809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-025-00809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:04:01Z","timestamp":1769519041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13293-025-00809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1186\/s13293-025-00809-1","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee at Brigham & Women\u2019s Hospital (IACUC protocol #2023N000080).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}